Multiple Myeloma: « 20 » and « 100 » Ratios Cut-off applicable to Sebia FLC assays

Publication
Oct. 14, 2022

The « 20 » and « 100 » Ratios Cut-off can be used in routine with Sebia FLC assays for high-risk smoldering multiple myeloma stratification and for assessing progression to active multiple myeloma or amyloidosis.

Newborn Screening for Sickle Cell Disease and other Haemoglobinopathies – MDPI – 2019

Publication
Jan. 12, 2022

This special Issue related to newborn screening for Sickle Cell disease and other hemoglobinopathies tried to cover the most widely faced challenges in the field of newborn screening for SCD.

Experience and recommendations of a Major Cancer Center to use HYDRASHIFT daratumumab

Publication
Août. 09, 2021

Immunotherapies for Multiple Myeloma, like the monoclonal antibody daratumumab, can create false positive IgG Kappa bands on Immunofixation gels. This paper describes best practice guidelines for using the Hydrashift assay to remove daratumumab interference from Immunofixation gels.

Further evaluation of the world health organization international reference reagent for Haemoglobin A2 measurement

Publication
Juin. 09, 2021

This article assesses the performances of the different manufacturers and technologies (HPLC and CE) for Hb A2 measurement using both International Reference Reagent for HbA2 (WHO IRR 89/666) and analysis of three whole blood specimens over a range of HbA2, distributed to 56 laboratories located in 14 different countries.

Pitfalls and ceveats of A1AT diagnosis

Publication
Juin. 09, 2021

Pitfalls and caveats in α1-antitrypsin deficiency testing: a guide for clinicians.

Evaluation of Sebia’s isoelectrofocusing kit for A1AT

Publication
Juin. 09, 2021

Evaluation of Sebia’s isoelectrofocusing kit for A1AT with HYDRASYS.

International standardization of CDT measurement

Publication
Juin. 09, 2021

IFCC CDT-Working Group standardized the CDT measurement.

Carbohydrate-deficient transferring testing: a truly traceable and specific biomarker for chronic alcohol misuse

Publication
Juin. 09, 2021

Article from Jean Deenmamode, IFCC CDT working group chair in CLI magazine.